FTC Finalizes Novartis Nicotine Patch Divestiture Deal
The Federal Trade Commission on Tuesday issued its final approval of a consumer health products joint venture between Novartis AG and GlaxoSmithKline PLC, after Novartis agreed to divest its Habitrol line...To view the full article, register now.
Already a subscriber? Click here to view full article